HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

G Remuzzi Selected Research

Lisinopril (Prinivil)

4/2006ACE inhibition reduces glomerulosclerosis and regenerates glomerular tissue in a model of progressive renal disease.
12/2000Protein traffic activates NF-kB gene signaling and promotes MCP-1-dependent interstitial inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


G Remuzzi Research Topics

Disease

20Proteinuria
02/2013 - 01/2000
15Chronic Kidney Failure (Chronic Renal Failure)
01/2016 - 01/2000
6Type 2 Diabetes Mellitus (MODY)
01/2009 - 06/2000
5Inflammation (Inflammations)
09/2017 - 01/2000
4Thrombotic Microangiopathies
06/2013 - 10/2000
4Thrombotic Thrombocytopenic Purpura
11/2009 - 01/2001
4Hemolytic-Uremic Syndrome
08/2006 - 03/2001
4Hypertension (High Blood Pressure)
11/2001 - 05/2000
4Thrombosis (Thrombus)
09/2001 - 08/2000
4Disease Progression
09/2001 - 01/2000
3Infections
08/2013 - 01/2001
3Atypical Hemolytic Uremic Syndrome
06/2013 - 11/2005
3Membranous Glomerulonephritis (Membranous Nephropathy)
05/2010 - 12/2000
3Albuminuria
01/2009 - 05/2006
3Chronic Renal Insufficiency
01/2004 - 01/2001
2Acute Kidney Injury (Acute Renal Failure)
04/2014 - 03/2007
2Renal Insufficiency (Renal Failure)
09/2012 - 01/2008
2Skin Neoplasms (Skin Cancer)
07/2007 - 11/2000
2Thrombocytopenia (Thrombopenia)
03/2007 - 01/2001
2Lupus Nephritis
07/2006 - 08/2001
2Heart Failure
10/2001 - 09/2001
1Reperfusion Injury
09/2017
1Ischemia
05/2014
1Meningococcal Infections
06/2013
1Chronic Disease (Chronic Diseases)
06/2013
1Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
02/2013
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
06/2009
1Body Weight (Weight, Body)
01/2009
1Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
02/2008
1Glomerulonephritis
02/2008
1Diabetic Nephropathies (Diabetic Nephropathy)
12/2007
1Carcinogenesis
07/2007
1Actinic Keratosis
07/2007
1Basal Cell Carcinoma (Rodent Ulcer)
07/2007
1Neoplasms (Cancer)
07/2007
1Carcinoma (Carcinomatosis)
07/2007
1Hemolytic Anemia
03/2007
1Cardiovascular Diseases (Cardiovascular Disease)
10/2006
1Autoimmune Diseases (Autoimmune Disease)
07/2006
1Sclerosis
04/2006
1Kidney Diseases (Kidney Disease)
04/2006
1Cytomegalovirus Infections (Inclusion Disease)
01/2004
1Fabry Disease (Fabry's Disease)
12/2003
1Atrophy
11/2001
1Genetic Predisposition to Disease (Genetic Predisposition)
09/2001
1Nephritis
08/2001

Drug/Important Bio-Agent (IBA)

12Proteins (Proteins, Gene)FDA Link
08/2013 - 03/2000
10CreatinineIBA
01/2016 - 05/2000
10Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2009 - 01/2000
6Complement System Proteins (Complement)IBA
09/2017 - 01/2001
5Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
04/2006 - 01/2000
4AlbuminsIBA
01/2016 - 03/2000
4thiamine triphosphorate (TTP)IBA
11/2009 - 01/2001
4Antihypertensive Agents (Antihypertensives)IBA
01/2009 - 03/2000
4Losartan (Cozaar)FDA LinkGeneric
05/2006 - 12/2000
4Angiotensin IIIBA
05/2006 - 12/2000
4Ramipril (Altace)FDA LinkGeneric
01/2001 - 01/2000
3Shiga Toxin (Shigella Toxin)IBA
07/2010 - 11/2005
3von Willebrand FactorIBA
09/2001 - 10/2000
2Rituximab (Mabthera)FDA Link
05/2010 - 01/2001
2CalciumIBA
01/2009 - 11/2001
2Angiotensin Receptor AntagonistsIBA
01/2009 - 09/2001
2Complement Factor H (Factor H)IBA
02/2008 - 03/2001
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
07/2007 - 08/2001
2SteroidsIBA
07/2006 - 08/2001
2Lisinopril (Prinivil)FDA LinkGeneric
04/2006 - 12/2000
1AntigensIBA
09/2017
1SurvivinIBA
05/2014
1Shiga Toxins (Vero Toxin)IBA
08/2013
1Complement Inactivating AgentsIBA
06/2013
1eculizumabFDA Link
06/2013
1Complement C3 (C3 Complement)IBA
09/2012
1paricalcitol (Zemplar)FDA Link
01/2009
1Calcitriol Receptors (Calcitriol Receptor)IBA
01/2009
1Parathyroid Hormone (Parathormone)IBA
01/2009
12,4-thiazolidinedione (thiazolidinedione)IBA
12/2007
1ProstaglandinsIBA
07/2007
13' Untranslated Regions (3' UTR)IBA
07/2007
1Aligeron (AS 2)IBA
10/2006
1A-factor (Streptomyces)IBA
08/2006
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
07/2006
1Tyrosine Kinase InhibitorsIBA
07/2006
1Imatinib Mesylate (Gleevec)FDA Link
07/2006
1Isoantigens (Alloantigen)IBA
01/2004
1Immunologic Factors (Immunomodulators)IBA
01/2004
1LipidsIBA
12/2003
1lacidipineIBA
11/2001
1P-SelectinIBA
09/2001
1Abciximab (ReoPro)FDA Link
09/2001
1Integrin alphaVbeta3IBA
09/2001
1Aurintricarboxylic AcidIBA
09/2001
1Platelet Membrane GlycoproteinsIBA
09/2001
1Platelet Endothelial Cell Adhesion Molecule-1IBA
09/2001
1Immunosuppressive Agents (Immunosuppressants)IBA
08/2001

Therapy/Procedure

15Therapeutics
06/2013 - 01/2000
7Kidney Transplantation
09/2017 - 07/2001
4Transplantation
06/2009 - 11/2000
2Plasma Exchange
06/2013 - 01/2008
2Organ Transplantation
07/2007 - 01/2001
1Enzyme Replacement Therapy
12/2003